Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond

This roundtable focuses on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders. Listen as the panel discuss novel innovations and strategies to accelerate timelines within preclinical development of your gene therapy, optimizing analytical test development and validation for dose analysis, molecular bioanalysis, transgene bioanalysis and immunogenicity and utilizing unique in vivo models requiring complex methods and routes of administration.